231 related articles for article (PubMed ID: 24066967)
1. New insights into the synergism of nucleoside analogs with radiotherapy.
Lee MW; Parker WB; Xu B
Radiat Oncol; 2013 Sep; 8():223. PubMed ID: 24066967
[TBL] [Abstract][Full Text] [Related]
2. The expression and activity of thymidine kinase 1 and deoxycytidine kinase are modulated by hydrogen peroxide and nucleoside analogs.
Sun R; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1347-1358. PubMed ID: 32189555
[TBL] [Abstract][Full Text] [Related]
3. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
Staub M
Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
[TBL] [Abstract][Full Text] [Related]
4. Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs.
Geutjes EJ; Tian S; Roepman P; Bernards R
Breast Cancer Res Treat; 2012 Feb; 131(3):809-18. PubMed ID: 21465168
[TBL] [Abstract][Full Text] [Related]
5. 2'-O-(2-Methoxyethyl) Nucleosides Are Not Phosphorylated or Incorporated Into the Genome of Human Lymphoblastoid TK6 Cells.
Saleh AF; Bachman M; Priestley CC; Gooderham NJ; Andersson P; Henry SP; Edmunds NJ; Fellows MD
Toxicol Sci; 2018 May; 163(1):70-78. PubMed ID: 29325107
[TBL] [Abstract][Full Text] [Related]
6. The subcellular location of nucleoside analog phosphorylation is a determinant of synergistic effects of hydroxyurea.
Zhu C; Johansson M; Karlsson A
Biochem Biophys Res Commun; 2000 Sep; 276(1):179-82. PubMed ID: 11006103
[TBL] [Abstract][Full Text] [Related]
7. Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance.
Bunimovich YL; Nair-Gill E; Riedinger M; McCracken MN; Cheng D; McLaughlin J; Radu CG; Witte ON
PLoS One; 2014; 9(8):e104125. PubMed ID: 25101980
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase.
Sabini E; Hazra S; Konrad M; Burley SK; Lavie A
Nucleic Acids Res; 2007; 35(1):186-92. PubMed ID: 17158155
[TBL] [Abstract][Full Text] [Related]
9. A crucial role for ATR in the regulation of deoxycytidine kinase activity.
Beyaert M; Starczewska E; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2016 Jan; 100():40-50. PubMed ID: 26620371
[TBL] [Abstract][Full Text] [Related]
10. Potential of ribozymes against deoxycytidine kinase to confer drug resistance to cytosine nucleoside analogs.
Beauséjour CM; Tremblay G; Momparler RL
Biochem Biophys Res Commun; 2000 Nov; 278(3):569-75. PubMed ID: 11095951
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
12. Identification of residues involved in the substrate specificity of human and murine dCK.
Usova EV; Eriksson S
Biochem Pharmacol; 2002 Dec; 64(11):1559-67. PubMed ID: 12429345
[TBL] [Abstract][Full Text] [Related]
13. The Role of Deoxycytidine Kinase (dCK) in Radiation-Induced Cell Death.
Zhong R; Xin R; Chen Z; Liang N; Liu Y; Ma S; Liu X
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27879648
[TBL] [Abstract][Full Text] [Related]
14. Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release.
Hazra S; Szewczak A; Ort S; Konrad M; Lavie A
Biochemistry; 2011 Apr; 50(14):2870-80. PubMed ID: 21351740
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside analogs as a radiosensitizer modulating DNA repair, cell cycle checkpoints, and apoptosis.
Yasui H; Iizuka D; Hiraoka W; Kuwabara M; Matsuda A; Inanami O
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):439-452. PubMed ID: 31560250
[TBL] [Abstract][Full Text] [Related]
16. An Escherichia coli system expressing human deoxyribonucleoside salvage enzymes for evaluation of potential antiproliferative nucleoside analogs.
Wang J; Neuhard J; Eriksson S
Antimicrob Agents Chemother; 1998 Oct; 42(10):2620-5. PubMed ID: 9756765
[TBL] [Abstract][Full Text] [Related]
17. Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage.
Yang C; Lee M; Hao J; Cui X; Guo X; Smal C; Bontemps F; Ma S; Liu X; Engler D; Parker WB; Xu B
Nucleic Acids Res; 2012 Oct; 40(19):9621-32. PubMed ID: 22850745
[TBL] [Abstract][Full Text] [Related]
18. Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.
Johnsamuel J; Eriksson S; Oliveira M; Tjarks W
Bioorg Med Chem; 2005 Jul; 13(13):4160-7. PubMed ID: 15876539
[TBL] [Abstract][Full Text] [Related]
19. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity.
Spasokoukotskaja T; Sasvári-Székely M; Keszler G; Albertioni F; Eriksson S; Staub M
Eur J Cancer; 1999 Dec; 35(13):1862-7. PubMed ID: 10674004
[TBL] [Abstract][Full Text] [Related]
20. Deoxycytidine kinase participates in the regulation of radiation-induced autophagy and apoptosis in breast cancer cells.
Zhong R; Liang B; Xin R; Zhu X; Liu Z; Chen Q; Hou Y; Jin Z; Qi M; Ma S; Liu X
Int J Oncol; 2018 Mar; 52(3):1000-1010. PubMed ID: 29393406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
